Victoria L. Holt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Victoria L. Holt has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Janet R. Daling
Program in Epidemiology Fred Hutchinson Cancer Research Center Seattle WA
3 shared publicationsKara L. Cushing-Haugen
Program in Epidemiology Fred Hutchinson Cancer Research Center Seattle WA
2 shared publicationsMarsha E. Wolf
2 shared publicationsMary A. Kernic
2 shared publications- Amy E. Bonomi
Center for Health Studies, Department of Obstetrics and Gynecology, Group Health Cooperative, Seattle, Washington 98101, USA
1 shared publication Andy Stergachis
1 shared publication
Latest Publications
- 14 November 2005
- Published by Elsevier in Social Science & Medicine
- Vol. 62 (9) , 2258-2266
Conversational silence, coercion, equality: The role of language in influencing who gets identified as abused
- 14 November 2005
- Published by Elsevier in Social Science & Medicine
- Vol. 62 (9) , 2258-2266
Conversational silence, coercion, equality: The role of language in influencing who gets identified as abused
- Open Access
- 3 March 2005
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 161 (6) , 520-525
Risk of Functional Ovarian Cyst: Effects of Smoking and Marijuana Use according to Body Mass Index
Smoking is one of the few risk factors that have been identified for functional ovarian cysts, and results of one epidemiologic study suggest that body mass index (BMI; weight (kg)/height (m)2) may modify the effect of this exposure. The current study assessed the association of cigarette smoking and marijuana use with functional ovarian cyst risk by using data from a population-based 1990–1995 case-control study of 586 incident functional ovarian cyst cases and 757 age-matched controls in a large health maintenance organization in Washington State. In multivariate analyses controlling for age, education, and reference year, the authors found an increase in risk associated with current cigarette smoking among women whose BMI was 25 (OR = 0.85, 95% CI: 0.53, 1.37). Corresponding risks associated with current marijuana use were BMI 25, OR = 0.72 (95% CI: 0.36, 1.42). Study results indicate that increased BMI may attenuate the adverse effect of smoking on the risk of functional ovarian cyst.
- 3 March 2005
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 161 (6) , 520-525
Open AccessRisk of Functional Ovarian Cyst: Effects of Smoking and Marijuana Use according to Body Mass Index
Smoking is one of the few risk factors that have been identified for functional ovarian cysts, and results of one epidemiologic study suggest that body mass index (BMI; weight (kg)/height (m)2) may modify the effect of this exposure. The current study assessed the association of cigarette smoking and marijuana use with functional ovarian cyst risk by using data from a population-based 1990–1995 case-control study of 586 incident functional ovarian cyst cases and 757 age-matched controls in a large health maintenance organization in Washington State. In multivariate analyses controlling for age, education, and reference year, the authors found an increase in risk associated with current cigarette smoking among women whose BMI was 25 (OR = 0.85, 95% CI: 0.53, 1.37). Corresponding risks associated with current marijuana use were BMI 25, OR = 0.72 (95% CI: 0.36, 1.42). Study results indicate that increased BMI may attenuate the adverse effect of smoking on the risk of functional ovarian cyst.
- 1 January 2005
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 105 (1) , 46-52
Body Mass Index, Weight, and Oral Contraceptive Failure Risk
OBJECTIVE: This project was supported by grant 1 R01 HD-34712 from the U.S. National Institute of Child Health and Human Development. To estimate the effect of body mass index (BMI) and weight on risk of pregnancy while using oral contraceptives (OCs). METHODS: We conducted a case-control study of 248 health maintenance organization enrollees who became pregnant while using OCs between 1998 and 2001 and 533 age-matched enrollees who were nonpregnant OC users during the same period. Using logistic regression we calculated adjusted odds ratios (ORs) to estimate the risk of pregnancy according to BMI and weight quartile. RESULTS: Among all OC users, when compared with women having a BMI of 27.3 or less, the risk of pregnancy was nearly 60% higher in women with BMI greater than 27.3 (OR 1.58, 95% confidence interval [CI] 1.11–2.24) and over 70% higher in women with BMI greater than 32.2 (OR 1.72, 95% CI 1.04–2.82). Among consistent users (women who missed no pills in reference month), the risk of pregnancy was more than doubled in women with BMI greater than 27.3 (OR 2.17, 95% CI 1.38–3.41) or BMI greater than 32.2 (OR 2.22, 95% CI 1.18–4.20). When compared with women weighing 74.8 kg or less, among consistent OC users the risk of pregnancy was over 70% higher in women weighing more than 74.8 kg (OR 1.71, 95% CI 1.08–2.71) and nearly doubled in women weighing more than 86.2 kg (OR 1.95, 95% CI 1.06–3.67). CONCLUSION: Our results suggest that being overweight may increase the risk of becoming pregnant while using OCs. If causal, this association translates to an additional 2–4 pregnancies per 100 woman-years of use among overweight women, for whom consideration of additional or effective alternative contraceptive methods may be warranted. LEVEL OF EVIDENCE: II-2
- 1 January 2005
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 105 (1) , 46-52
Body Mass Index, Weight, and Oral Contraceptive Failure Risk
OBJECTIVE: This project was supported by grant 1 R01 HD-34712 from the U.S. National Institute of Child Health and Human Development. To estimate the effect of body mass index (BMI) and weight on risk of pregnancy while using oral contraceptives (OCs). METHODS: We conducted a case-control study of 248 health maintenance organization enrollees who became pregnant while using OCs between 1998 and 2001 and 533 age-matched enrollees who were nonpregnant OC users during the same period. Using logistic regression we calculated adjusted odds ratios (ORs) to estimate the risk of pregnancy according to BMI and weight quartile. RESULTS: Among all OC users, when compared with women having a BMI of 27.3 or less, the risk of pregnancy was nearly 60% higher in women with BMI greater than 27.3 (OR 1.58, 95% confidence interval [CI] 1.11–2.24) and over 70% higher in women with BMI greater than 32.2 (OR 1.72, 95% CI 1.04–2.82). Among consistent users (women who missed no pills in reference month), the risk of pregnancy was more than doubled in women with BMI greater than 27.3 (OR 2.17, 95% CI 1.38–3.41) or BMI greater than 32.2 (OR 2.22, 95% CI 1.18–4.20). When compared with women weighing 74.8 kg or less, among consistent OC users the risk of pregnancy was over 70% higher in women weighing more than 74.8 kg (OR 1.71, 95% CI 1.08–2.71) and nearly doubled in women weighing more than 86.2 kg (OR 1.95, 95% CI 1.06–3.67). CONCLUSION: Our results suggest that being overweight may increase the risk of becoming pregnant while using OCs. If causal, this association translates to an additional 2–4 pregnancies per 100 woman-years of use among overweight women, for whom consideration of additional or effective alternative contraceptive methods may be warranted. LEVEL OF EVIDENCE: II-2
- 1 August 2003
- Published by Wolters Kluwer Health
- Vol. 102 (2) , 252-258
Oral contraceptives, tubal sterilization, and functional ovarian cyst risk
To determine whether current contraceptive method affects functional ovarian cyst risk, with emphasis on oral contraceptives (OCs) and tubal sterilization. We conducted a case–control study of 18–39-year-old health maintenance organization enrollees with a functional ovarian cyst diagnosed between January 1, and June 30, 1994, and age-matched female controls randomly selected from enrollment files. In-person interviews as well as medical and pharmacy records were obtained for 78% of cases and 82% of controls; these analyses were based on 392 cases and 623 controls. Odds ratios (ORs) calculated with unconditional logistic regression were used to estimate the risk of a functional ovarian cyst diagnosis associated with current contraceptive method. In multivariable analyses adjusting for age, education, number of live births, and reference year, the overall OR was 0.72 (95% confidence interval [CI] 0.53, 0.99) for current OC use, compared with use of nonsurgical nonhormonal contraception or no contraception. The risk associated with use of 35 μg ethinyl estradiol monophasic OCs (OR 0.69; 95% CI 0.44, 1.10) was slightly lower than that associated with less than 35 μg ethinyl estradiol monophasic (OR 0.79; 95% CI 0.43, 1.47) or multiphasic OCs (OR 0.76; 95% CI 0.49, 1.19). Women with tubal sterilization had a substantially increased risk of a functional ovarian cyst diagnosis (OR 1.70; 95% CI 1.05, 2.75) compared with women using nonhormonal or no contraception. Our findings suggest that low-dose OC use has little or no effect on functional ovarian cyst likelihood. The increased risks we found associated with tubal sterilization merit further investigation.
- 1 August 2003
- Published by Wolters Kluwer Health
- Vol. 102 (2) , 252-258
Oral contraceptives, tubal sterilization, and functional ovarian cyst risk
To determine whether current contraceptive method affects functional ovarian cyst risk, with emphasis on oral contraceptives (OCs) and tubal sterilization. We conducted a case–control study of 18–39-year-old health maintenance organization enrollees with a functional ovarian cyst diagnosed between January 1, and June 30, 1994, and age-matched female controls randomly selected from enrollment files. In-person interviews as well as medical and pharmacy records were obtained for 78% of cases and 82% of controls; these analyses were based on 392 cases and 623 controls. Odds ratios (ORs) calculated with unconditional logistic regression were used to estimate the risk of a functional ovarian cyst diagnosis associated with current contraceptive method. In multivariable analyses adjusting for age, education, number of live births, and reference year, the overall OR was 0.72 (95% confidence interval [CI] 0.53, 0.99) for current OC use, compared with use of nonsurgical nonhormonal contraception or no contraception. The risk associated with use of 35 μg ethinyl estradiol monophasic OCs (OR 0.69; 95% CI 0.44, 1.10) was slightly lower than that associated with less than 35 μg ethinyl estradiol monophasic (OR 0.79; 95% CI 0.43, 1.47) or multiphasic OCs (OR 0.76; 95% CI 0.49, 1.19). Women with tubal sterilization had a substantially increased risk of a functional ovarian cyst diagnosis (OR 1.70; 95% CI 1.05, 2.75) compared with women using nonhormonal or no contraception. Our findings suggest that low-dose OC use has little or no effect on functional ovarian cyst likelihood. The increased risks we found associated with tubal sterilization merit further investigation.
- Open Access
- 7 August 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (5) , 589-594
Civil Protection Orders and Risk of Subsequent Police-Reported Violence
Intimate partner violence (IPV) is a frequent occurrence in the United States, with nearly 5 million physical or sexual assaults by intimate partners experienced by approximately 1.5 million women annually.1 In addition to injury-related visits, abused women have high frequencies of emergency department visits and hospitalizations for somatic and psychiatric diagnoses related to stress, including functional gastrointestinal disorders, loss of appetite, chest pain, headaches, anxiety, insomnia, alcohol abuse or dependence, post-traumatic stress disorder, depression, and suicide attempts.2-5
- 7 August 2002
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (5) , 589-594
Open AccessCivil Protection Orders and Risk of Subsequent Police-Reported Violence
Intimate partner violence (IPV) is a frequent occurrence in the United States, with nearly 5 million physical or sexual assaults by intimate partners experienced by approximately 1.5 million women annually.1 In addition to injury-related visits, abused women have high frequencies of emergency department visits and hospitalizations for somatic and psychiatric diagnoses related to stress, including functional gastrointestinal disorders, loss of appetite, chest pain, headaches, anxiety, insomnia, alcohol abuse or dependence, post-traumatic stress disorder, depression, and suicide attempts.2-5
- Open Access
- 1 November 1989
- Published by JSTOR in Studies in Family Planning
- Vol. 20 (6) , 365
"Induced Abortion and the Risk of Subsequent Ectopic Pregnancy"
- 1 November 1989
- Published by JSTOR in Studies in Family Planning
- Vol. 20 (6) , 365
Open Access"Induced Abortion and the Risk of Subsequent Ectopic Pregnancy"